Literature DB >> 34404773

Intellectual disability and microcephaly associated with a novel CHAMP1 mutation.

Yuta Asakura1, Hitoshi Osaka2, Hiromi Aoi3, Takeshi Mizuguchi3, Naomichi Matsumoto3, Takanori Yamagata1.   

Abstract

Mutations in a number of genes related to chromosomal segregation reportedly cause developmental disorders, e.g., chromosome alignment-maintaining phosphoprotein 1 (CHAMP1). We report on an 8-year-old Japanese girl who presented with a developmental disorder and microcephaly and carries a novel nonsense mutation in CHAMP1. Therefore, CHAMP1 mutation should be considered as a differential diagnosis of global developmental delay and microcephaly.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34404773      PMCID: PMC8371100          DOI: 10.1038/s41439-021-00165-7

Source DB:  PubMed          Journal:  Hum Genome Var        ISSN: 2054-345X


Chromosome alignment-maintaining phosphoprotein 1 (CHAMP1) is a zinc finger protein that functions in kinetochore-microtubule attachment and regulates chromosome segregation. Pathogenic variants of CHAMP1 have been reported in patients with intellectual disability and other signs, such as microcephaly, muscular hypotonia, facial dysmorphism, and eye anomalies.[1-3] Here, we report a novel nonsense mutation in CHAMP1, NM_001164144.2:c.1465C>T, p.(Gln489*). The patient was an 8-year-old Japanese girl born to nonconsanguineous parents without neurological abnormalities, such as intellectual disability. She was delivered at full term by emergency Cesarean section because of umbilical cord entanglement without newborn asphyxia. Her birth weight was 2755 g (−0.47 standard deviation [SD]), her length was 46.8 cm (−1.5 SD), and her occipital frontal circumference was 31.8 cm (−0.9 SD). Her physical examination at birth was normal. She could control her head at 4 months of age and sit stably at 10 months. At 10 months of age, she developed acute encephalopathy after infection with respiratory syncytial virus and was treated with steroid pulse therapy in another hospital. She recovered without sequelae. However, since her recovery, developmental delay with acquired microcephaly (−2.4 SD) has become evident. Head magnetic resonance imaging was performed when she was 2 years old, and the scan showed mild atrophy of the cerebrum and cerebellum. She could walk independently at 3.5 years of age. At 4 years of age, she came to our hospital because of global intellectual disability and acquired microcephaly. At the time of the visit, she had severe intellectual disability and could speak no meaningful words. A physical examination revealed no abnormalities. She was very friendly and displayed no dysmorphic facial features. A neurological examination showed normal muscle tone and tendon reflexes. No pyramidal tract signs, dystonia, or involuntary movements were observed. Her intelligence quotient according to a Tanaka-Binet test was 35. As the acute encephalopathy caused no brain magnetic resonance imaging abnormalities or sequelae, we searched for the cause of her intellectual disability and microcephalus. We initially suspected Angelman syndrome; however, a fluorescence in situ hybridization analysis failed to show a microdeletion at 15q11.2. After receiving informed consent, we performed whole-exome sequencing as previously described.[4] We identified a novel de novo nonsense heterozygous variant, c.1465C>T, p.(Gln489*), in CHAMP1 (Fig. 1).
Fig. 1

Diagram of CHAMP1 variants.

Diagram of previously reported CHAMP1 variants (upper panel) and the mutation identified in this case (lower panel, underlined). CHAMP1 consists of five zinc-finger domains (ZNF) and several motifs; SPE (consensus: PxxSPExxK; dots), WK (SPxxWKxxP; diagonal lines), and FPE (FPExxK; grey bar).

Diagram of CHAMP1 variants.

Diagram of previously reported CHAMP1 variants (upper panel) and the mutation identified in this case (lower panel, underlined). CHAMP1 consists of five zinc-finger domains (ZNF) and several motifs; SPE (consensus: PxxSPExxK; dots), WK (SPxxWKxxP; diagonal lines), and FPE (FPExxK; grey bar). In addition to CHAMP1,[1-3] a number of mutations in genes related to chromosome alignment and/or spindle function, including Pogo transposable element-derived with ZNF domain (POGZ), tubulin gamma 1, dynein cytoplasmic 1 heavy chain 1, kinesin family member 5C (KIF5C), KIF2A, KIF4A, and centromere protein E, have been shown to cause various developmental disorders.[5-9] CHAMP1 contains several repeat motifs, i.e., SPE, WK, and FPE motifs, and regulates kinetochore-microtubule attachment and chromosome alignment (Fig. 1). These motifs reportedly play an important role in spindle localization and kinetochore-microtubule interactions.[10] The C-terminal region of CHAMP1, which contains the zinc-finger domain, has been predicted to be crucial for its proper localization to chromosomes and for mitotic spindle function.[1] Functional studies using various deletion mutants of CHAMP1 have shown that lack of the C-terminal region of CHAMP1 prevents proper chromosomal localization.[10] Similar to the CHAMP1 mutation in this case, all reported mutations are truncating mutations, i.e., nonsense or frameshift mutations that cause the loss of the C-terminal zinc-finger domain (Table 1). Although the biological mechanism that links CHAMP1 mutations and intellectual disability is unknown, the pathogenic mechanism appears to be a result of the loss of the C-terminal region of CHAMP1. POGZ binds to the C-terminal region of CHAMP1 and is critical for proper chromosome segregation.[3,11] Therefore, loss of the C-terminus may impair CHAMP1 chromosomal localization or/and its binding to other proteins, such as POGZ. Mitotic defects in neural progenitor cells may cause a decrease in the number of neural cells and defective neural development, resulting in intellectual disability.[3]
Table 1

CHAMP1 variants and clinical presentation.

PatientsSexMutationMuscle hypotoniaMicrocephalyDelay in walking (>18m)Impaired speech developmentEye anomaliesBrain MRISeizureAbnormal behaviorDysmorphic facial featuresReference
1Fc.542_543delCT p.Ser181*+++StrabismusN/AFebrile seizuresSkin-picking, rituals, food-foragingN/ATanaka et al.[2]
2Fc.635delC p. Pro212*+++Hyperopia, astigmatismNormalFriendly, hand stereotypy, tacle hypersensitivity, sexual self-stimulation+Hempel et al.[1]
3Fc.958_959delCC, p.Pro320*N/A++N/Anon specific patchy signal abnormalities in right parieto-occipital subcortical white matter, bulky corpus callosum autistic behavior++Isdor et al.[3]
4Mc.1002G>A p.Trp334*N/A++Hyperopia, strabismusNormal-Isdor et al.[3]
5Fc.1043G>A, p.Trp348*N/A+++Hyperopia, astigmatismthickening of the corpus callosum, subtle hypoplasia of the left temporal lobe++Isdor et al.[3]
6Fc.1044delG p.Trp348*+++Hypoplastic corpus callosumAggressive, occasionally self injuriousN/ATanaka et al.[2]
7Mc.1192C>T p.Arg398*++++Strabismus, hyperopiaNormalFriendly+Hempel et al.[1]
8Fc.1192C>T p.Arg398*++Hyperopia, astigmatismNormalFriendly+Hempel et al.[1]
9Fc.1465C>T, p.Gln489*+++mild atrophy of the cerebrum and cerebellumFriendlyThis case
10Fc.1489C>T, p.Arg497*N/A++AmblyopiaN/AN/A+Isdor et al.[3]
11Mc.1768C>T p.Gln590*++++Impaireddelayed myelinationFromtotemporal epilepsyHand stereotypy, friendly+Hempel et al.[1]
12Mc.1866_1867delCA p.Asp622*++++Strabismus, hyperopiaMild brain atrophy and cerebellar cortical dysplasiaHand stereotypy, friendly+Hempel et al.[1]
13Fc.1876_1877delAG; p.Ser626*N/A+++Hyperopia, astigmatismarachnoid cyst+++Isdor et al.[3]
14Mc.1880C>G p.Ser627*N/A+++Hyperopia, astigmatism, strabismusNormal+Isdor et al.[3]
15Fc.1945C>T p.Gln649*+++Ocuular albinismNormalADD/ADHDN/ATanaka et al.[2]
16Fc.1969C>T p.Gln657*++++StrabismusMild decreased white matterSeizure at 3 yoInapropriate laughterN/ATanaka et al.[2]
17Fc.2029G>T p.Glu677*++++StrabismusMild cerebellar atrophyHyperactivityN/ATanaka et al.[2]

+ present, − absent, N/A not available, ADD/ADHD attention deficit disorder/attention deficit hyperactivity disorder.

CHAMP1 variants and clinical presentation. + present, − absent, N/A not available, ADD/ADHD attention deficit disorder/attention deficit hyperactivity disorder. The clinical presentation of CHAMP1 mutation includes intellectual disability (17/17), motor development delay (14/17), facial dysmorphism (10/12), eye anomalies (14/16), and microcephaly (12/17). For some individuals, anomalies are evident on magnetic resonance imaging scans of the brain (9/15) and abnormal behavior varies from mild to severe (14/17) (Table 1).[1-3] Some patients present with a feeding disorder. Considering these symptoms, Angelman syndrome and Prader-Willi syndrome are the most important differential diagnoses.[1] In conclusion, we report a novel nonsense mutation in CHAMP1, c.1465C>T, p.(Gln489*). The patient had intellectual disability, motor development delay, and microcephaly but no facial dysmorphism or eye anomalies. CHAMP1 mutation should be considered when a patient presents with global developmental delay and microcephaly.

HGV database

The relevant data from this Data Report are hosted at the Human Genome Variation Database at 10.6084/m9.figshare.hgv.3081.
  11 in total

1.  De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment.

Authors:  Maja Hempel; Kirsten Cremer; Charlotte W Ockeloen; Klaske D Lichtenbelt; Johanna C Herkert; Jonas Denecke; Tobias B Haack; Alexander M Zink; Jessica Becker; Eva Wohlleber; Jessika Johannsen; Bader Alhaddad; Rolph Pfundt; Sigrid Fuchs; Dagmar Wieczorek; Tim M Strom; Koen L I van Gassen; Tjitske Kleefstra; Christian Kubisch; Hartmut Engels; Davor Lessel
Journal:  Am J Hum Genet       Date:  2015-09-03       Impact factor: 11.025

2.  De Novo Truncating Mutations in the Kinetochore-Microtubules Attachment Gene CHAMP1 Cause Syndromic Intellectual Disability.

Authors:  Bertrand Isidor; Sébastien Küry; Jill A Rosenfeld; Thomas Besnard; Sébastien Schmitt; Shelagh Joss; Sally J Davies; Robert Roger Lebel; Alex Henderson; Christian P Schaaf; Haley E Streff; Yaping Yang; Vani Jain; Nodoka Chida; Xenia Latypova; Cédric Le Caignec; Benjamin Cogné; Sandra Mercier; Marie Vincent; Estelle Colin; Dominique Bonneau; Anne-Sophie Denommé; Philippe Parent; Brigitte Gilbert-Dussardier; Sylvie Odent; Annick Toutain; Amélie Piton; Christian Dina; Audrey Donnart; Pierre Lindenbaum; Eric Charpentier; Richard Redon; Kenji Iemura; Masanori Ikeda; Kozo Tanaka; Stéphane Bézieau
Journal:  Hum Mutat       Date:  2016-02-04       Impact factor: 4.878

3.  Whole exome sequencing of fetal structural anomalies detected by ultrasonography.

Authors:  Hiromi Aoi; Takeshi Mizuguchi; Toshifumi Suzuki; Shintaro Makino; Yuka Yamamoto; Jun Takeda; Yojiro Maruyama; Rie Seyama; Shiori Takeuchi; Yuri Uchiyama; Yoshiteru Azuma; Kohei Hamanaka; Atsushi Fujita; Eriko Koshimizu; Satoko Miyatake; Satomi Mitsuhashi; Atsushi Takata; Noriko Miyake; Satoru Takeda; Atsuo Itakura; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2020-11-03       Impact factor: 3.172

4.  Involvement of the kinesin family members KIF4A and KIF5C in intellectual disability and synaptic function.

Authors:  Marjolein H Willemsen; Wei Ba; Willemijn M Wissink-Lindhout; Arjan P M de Brouwer; Stefan A Haas; Melanie Bienek; Hao Hu; Lisenka E L M Vissers; Hans van Bokhoven; Vera Kalscheuer; Nael Nadif Kasri; Tjitske Kleefstra
Journal:  J Med Genet       Date:  2014-05-08       Impact factor: 6.318

5.  Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B.

Authors:  Sandra Hanks; Kim Coleman; Sarah Reid; Alberto Plaja; Helen Firth; David Fitzpatrick; Alexa Kidd; Károly Méhes; Richard Nash; Nathanial Robin; Nora Shannon; John Tolmie; John Swansbury; Alexandre Irrthum; Jenny Douglas; Nazneen Rahman
Journal:  Nat Genet       Date:  2004-10-10       Impact factor: 38.330

6.  Mutations in CENPE define a novel kinetochore-centromeric mechanism for microcephalic primordial dwarfism.

Authors:  Ghayda M Mirzaa; Benjamin Vitre; Gillian Carpenter; Iga Abramowicz; Joseph G Gleeson; Alex R Paciorkowski; Don W Cleveland; William B Dobyns; Mark O'Driscoll
Journal:  Hum Genet       Date:  2014-04-20       Impact factor: 4.132

7.  Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.

Authors:  Karine Poirier; Nicolas Lebrun; Loic Broix; Guoling Tian; Yoann Saillour; Cécile Boscheron; Elena Parrini; Stephanie Valence; Benjamin Saint Pierre; Madison Oger; Didier Lacombe; David Geneviève; Elena Fontana; Franscesca Darra; Claude Cances; Magalie Barth; Dominique Bonneau; Bernardo Dalla Bernadina; Sylvie N'guyen; Cyril Gitiaux; Philippe Parent; Vincent des Portes; Jean Michel Pedespan; Victoire Legrez; Laetitia Castelnau-Ptakine; Patrick Nitschke; Thierry Hieu; Cecile Masson; Diana Zelenika; Annie Andrieux; Fiona Francis; Renzo Guerrini; Nicholas J Cowan; Nadia Bahi-Buisson; Jamel Chelly
Journal:  Nat Genet       Date:  2013-04-21       Impact factor: 38.330

8.  Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation.

Authors:  Ryu-Suke Nozawa; Koji Nagao; Hiro-Taka Masuda; Osamu Iwasaki; Toru Hirota; Naohito Nozaki; Hiroshi Kimura; Chikashi Obuse
Journal:  Nat Cell Biol       Date:  2010-06-20       Impact factor: 28.213

9.  De novo pathogenic variants in CHAMP1 are associated with global developmental delay, intellectual disability, and dysmorphic facial features.

Authors:  Akemi J Tanaka; Megan T Cho; Kyle Retterer; Julie R Jones; Catherine Nowak; Jessica Douglas; Yong-Hui Jiang; Allyn McConkie-Rosell; G Bradley Schaefer; Julie Kaylor; Omar A Rahman; Aida Telegrafi; Bethany Friedman; Ganka Douglas; Kristin G Monaghan; Wendy K Chung
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-01

10.  Large-scale discovery of novel genetic causes of developmental disorders.

Authors: 
Journal:  Nature       Date:  2014-12-24       Impact factor: 69.504

View more
  1 in total

1.  Deficiency of CHAMP1, a gene related to intellectual disability, causes impaired neuronal development and a mild behavioural phenotype.

Authors:  Masayoshi Nagai; Kenji Iemura; Takako Kikkawa; Sharmin Naher; Satoko Hattori; Hideo Hagihara; Koh-Ichi Nagata; Hayato Anzawa; Risa Kugisaki; Hideki Wanibuchi; Takaya Abe; Kenichi Inoue; Kengo Kinoshita; Tsuyoshi Miyakawa; Noriko Osumi; Kozo Tanaka
Journal:  Brain Commun       Date:  2022-08-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.